The cost-effectiveness of infliximab (Remicade((R))) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study.
(2003) In Rheumatology 42(2). p.326-335
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/112262
- author
- Kobelt, G ; Jönsson, L ; Young, A and Eberhardt, Kerstin LU
- organization
- publishing date
- 2003
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Rheumatology
- volume
- 42
- issue
- 2
- pages
- 326 - 335
- publisher
- Oxford University Press
- external identifiers
-
- pmid:12595631
- wos:000181378100021
- scopus:0345294739
- ISSN
- 1462-0332
- DOI
- 10.1093/rheumatology/keg107
- language
- English
- LU publication?
- yes
- id
- 8b8b9db8-e095-4143-bef3-ec64b52810f3 (old id 112262)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12595631&dopt=Abstract
- date added to LUP
- 2016-04-01 16:04:32
- date last changed
- 2022-03-07 03:22:58
@article{8b8b9db8-e095-4143-bef3-ec64b52810f3,
author = {{Kobelt, G and Jönsson, L and Young, A and Eberhardt, Kerstin}},
issn = {{1462-0332}},
language = {{eng}},
number = {{2}},
pages = {{326--335}},
publisher = {{Oxford University Press}},
series = {{Rheumatology}},
title = {{The cost-effectiveness of infliximab (Remicade((R))) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study.}},
url = {{http://dx.doi.org/10.1093/rheumatology/keg107}},
doi = {{10.1093/rheumatology/keg107}},
volume = {{42}},
year = {{2003}},
}